Overview
Angela Wellman is an Oncologist in Chillicothe, Ohio. Her top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Muscle Invasive Bladder Cancer, and Non-Muscle Invasive Bladder Cancer.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- HMO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- PPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
4435 State Route 159, Chillicothe, OH 45601
Osu Medical Center
Manisha Shah is an Oncologist in Columbus, Ohio. Dr. Shah is highly rated in 19 conditions, according to our data. Her top areas of expertise are Neuroendocrine Tumor, Thyroid Cancer, Medullary Thyroid Carcinoma, Pancreaticoduodenectomy, and Liver Embolization.
Ohio State University Hospital-Pavilion
David Carbone is an Oncologist in Columbus, Ohio. Dr. Carbone is highly rated in 11 conditions, according to our data. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and Tissue Biopsy.
Nationwide Children's Hospital
Maryam Fouladi is a Hematologist and an Oncologist in Columbus, Ohio. Dr. Fouladi is highly rated in 10 conditions, according to our data. Her top areas of expertise are Diffuse Midline Glioma H3 K27M-Mutant, Glioma, Medulloblastoma, and Brain Stem Cancer.
Frequently Asked Questions about Angela Wellman, NP
How do I make an appointment with Angela Wellman, NP?
You can book an appointment with Angela Wellman, NP by calling their office at 740-542-3030. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Angela Wellman, NP a top-rated expert for ALK-Positive Non-Small Cell Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Angela Wellman, NP is classified as an Experienced expert for ALK-Positive Non-Small Cell Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Angela Wellman, NP specialize in?
While Angela Wellman, NP is a Oncology, they have specific expertise in ALK-Positive Non-Small Cell Lung Cancer, Muscle Invasive Bladder Cancer, and Non-Muscle Invasive Bladder Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Angela Wellman, NP accept my insurance?
Angela Wellman, NP accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 740-542-3030 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ALK-Positive Non-Small Cell Lung CancerMs. Wellman isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Muscle Invasive Bladder CancerMs. Wellman isExperienced. Learn about Muscle Invasive Bladder Cancer.
- Non-Muscle Invasive Bladder CancerMs. Wellman isExperienced. Learn about Non-Muscle Invasive Bladder Cancer.